Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

After more than a century of battling heart disease as the number one killer of Americans, you would think we’d know all about it. For a good part of the 20th century, cardiologists thought they had ...

Lipoprotein(a) levels greater 30 mg/dL linked to increased 30-year risk for major CV events and coronary heart disease.

Contemporary guidelines do not generally endorse universal screening ...

A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...

A new study has found that high cholesterol increases the 30-year risk of heart disease, even in healthy women.

A new study published in the Journal of American Medical Association showed that among healthy women, very high lipoprotein ...

When considering the risk factors for heart disease, some conditions may come readily to mind: obesity, unhealthy diet, and high cholesterol. People who have a parent or close relative with heart ...

Every Australian adult should be screened for a potentially deadly type of inherited cholesterol, and if the simple blood ...